Roche has secured CE mark for its smartphone app that allows users to measure blood glucose level without the need of a meter.

Known as Accu-Chek SugarView, the app determines blood glucose ranges by taking photos with the smartphone camera.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company said that the app is specifically designed to aid non-insulin-dependent patients with type 2 diabetes.

By utilising the Accu-Chek Active test strip and two photos from the strip from a smartphone camera, the app determines the blood glucose level in the body.

The app then analyses the result on the test strip via an algorithm that categorises the blood glucose range from low to very high.

Along with the blood glucose level, the app also provides users with information on actions to take, like exercise or eating.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Globally, approximately 463 million adults are suffering from diabetes. Type 2 diabetes is the most common form.

This CE mark will enable the company to commercialise its Accu-Chek SugarView app in Europe and other countries where the CE mark is required.

Roche diabetes care global head Marcel Gmuender said: “Non-insulin dependent people with type 2 diabetes or pre-diabetes can gain a better understanding of how to live a healthier life through learning how their blood glucose range can vary as a result of their actions.

“Accu-Chek SugarView is an easy-to-use app. In addition, it bypasses the need for a blood glucose meter, making it a very affordable and convenient diabetes management solution.

“This is especially crucial in emerging markets with often limited access to care and scarce healthcare resources, as the app enables availability of relevant therapy information and support in everyday life.”

Initially, the blood glucose monitoring app will be available on the Google Play store for specific smartphone models only.